Ibuprofen Lysine

CHEMBL1201141 Phase 4 Đã phê duyệt Small molecule
Half-Life
Bioavailability
Protein Binding
Molecular Weight
352.5 g/mol
LogP
Phase
4

This is the lysine salt form of ibuprofen, which may dissolve more quickly than standard ibuprofen, potentially providing faster onset of pain relief. The lysine conjugate improves the solubility of ibuprofen for certain formulations, including intravenous use for closing patent ductus arteriosus in premature infants. It shares the anti-inflammatory, analgesic, and antipyretic properties of ibuprofen.

Khối lượng phân tử

352,5000 g/mol

TPSA

127,00 Ų

Lĩnh vực điều trị

Cơ chế tác dụng

Non-selective COX inhibitor reducing prostaglandin synthesis.

Pharmacokinetics (PK)

Pharmacodynamics (PD)

Cơ chế

Non-selective COX inhibitor reducing prostaglandin synthesis.

Cấu trúc 2D

SVG PNG

Cite this structure


                        

Embed this structure


                        

SMILES

CC(C)Cc1ccc(C(C)C(=O)O)cc1.NCCCC[C@H](N)C(=O)O

InChI

InChI=1S/C13H18O2.C6H14N2O2/c1-9(2)8-11-4-6-12(7-5-11)10(3)13(14)15;7-4-2-1-3-5(8)6(9)10/h4-7,9-10H,8H2,1-3H3,(H,14,15);5H,1-4,7-8H2,(H,9,10)/t;5-/m.0/s1

Molecular Formula

C19H32N2O4

HBD / HBA

4 / 6

Liên kết có thể quay

9

Nguyên tử nặng

25

No targets recorded

Target interaction data is not yet available for this drug.

No interactions recorded

Drug interaction data is not yet available for this compound.

No side effects recorded

Side effect data is not yet available for this drug.

Câu hỏi thường gặp

This is the lysine salt form of ibuprofen, which may dissolve more quickly than standard ibuprofen, potentially providing faster onset of pain relief. The lysine conjugate improves the solubility of ibuprofen for certain formulations, including intravenous use for closing patent ductus arteriosus in premature infants. It shares the anti-inflammatory, analgesic, and antipyretic properties of ibuprofen.

Non-selective COX inhibitor reducing prostaglandin synthesis.

Yes, Ibuprofen Lysine is an approved drug. It has reached clinical phase 4. It is classified as a Small molecule.

{# References & Data Sources section for drug detail pages. Renders standard pharmacological database links plus the drug's data_sources field. #}

References & Data Sources

  • ChEMBL — European Bioinformatics Institute (EBI). CHEMBL1201141. Open-access bioactivity database.
  • PubChem — National Center for Biotechnology Information (NCBI). CID 9841440. Chemical information database.

Data aggregated from publicly available pharmacological databases. Last updated 2026-03-04.

Tuyên bố miễn trách y tế

This content is for educational and informational purposes only. It is not a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making medication decisions.

Data sources: ChEMBL, PubChem, DailyMed.